about
Pax6 3' deletion results in aniridia, autism and mental retardationIdentification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane.Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data.G72 influences longitudinal change in frontal lobe volume in schizophrenia.Toward defining schizophrenia as a more useful clinical concept.Perceived stress in prodromal Huntington disease.Correlation of CAG repeat length between the maternal and paternal allele of the Huntingtin gene: evidence for assortative mating.Depressive symptoms related to low fractional anisotropy of white matter underlying the right ventral anterior cingulate in older adults with atherosclerotic vascular disease.Measures of growth in children at risk for Huntington diseaseBasic helix-loop-helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilitiesPatterns of serotonergic antidepressant usage in prodromal Huntington diseaseUnawareness of motor phenoconversion in Huntington disease.Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease.Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia.Identification of interdependent signals required for anterograde traffic of the ATP-binding cassette transporter protein Yor1p.A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.Yap1p activates gene transcription in an oxidant-specific fashionStatistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes.Sex-specific effects of the Huntington gene on normal neurodevelopment.A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington's disease.Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism.Effect of Trinucleotide Repeats in the Huntington's Gene on Intelligence.A genome-wide CNV analysis of schizophrenia reveals a potential role for a multiple-hit modelBrain structure in juvenile-onset Huntington disease.Abnormal brain development in child and adolescent carriers of mutant huntingtin
P50
Q24658076-5B38477C-15EF-4B24-A5B8-B1C176CB97D2Q27934844-F03521FD-B9FA-4AAD-AB0F-7A923CB0DE53Q30855262-DD20F4FD-AA09-404E-AEDB-4B30088CE11BQ34013842-FDAA5D7D-80CE-4A3A-A458-B6BB20C83370Q34796205-3D7D15DC-0951-49C7-B4B4-596EC10EEC04Q35190719-3AFD6C30-5D30-4B48-94D0-06F1FCD77A7AQ35560130-15AE4F16-21AC-403B-9DBC-EF35D568F613Q35851804-F45C87BF-23D8-469E-99BA-0465D4C0928DQ36149988-620C9566-D36A-495F-9BEE-1E0D932BE577Q37002050-9D9C99A5-8D00-4243-8FA5-38678C9A620DQ37148863-985DC1DA-CD2A-4E62-B856-01F5D25627B1Q37227051-4170E7FB-4A38-4BE3-B78B-062ACA2584E4Q37250423-A1F18F52-5437-4A81-921B-22F78C9163B0Q37254698-0D843896-C14D-4092-8B18-7712A7649221Q37367250-426CA215-6A6E-4E08-910F-6E82D67EC4E9Q38287342-0C8D910E-7999-4AA1-85FE-72AAAFC4AFF9Q38383918-0DAEA700-9B95-4636-AA40-464CA10D26B5Q39449336-3B575DCB-F51E-46F7-8C77-72A061F63549Q39727461-A28A9CA4-CBAC-48E4-8244-CEE844E0F9ABQ45299048-063B2874-BFCF-4BCC-9357-5703BC8F3100Q45305006-E8E901EA-2A5D-4EBF-B1C9-DE3025DD5492Q48147016-2B4BA088-2C95-4C32-B31D-19DF415AB349Q55285159-DE7BFD6B-06CF-48F2-B573-087DB4481A3BQ63869335-01CED6F6-0A15-4629-9DD0-727305051BF8Q64886062-DD5E4C21-4D08-474B-992E-C63EB151231DQ92352087-8AAD40C4-E8A6-42F4-B24D-37F9A2824E59
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7193-3041
@en
name
Eric Epping
@ast
Eric Epping
@en
Eric Epping
@es
Eric Epping
@nl
type
label
Eric Epping
@ast
Eric Epping
@en
Eric Epping
@es
Eric Epping
@nl
prefLabel
Eric Epping
@ast
Eric Epping
@en
Eric Epping
@es
Eric Epping
@nl
P106
P1153
6604065649
P31
P496
0000-0001-7193-3041